Beyond the physical changes, its important to acknowledge the emotional impact of skin laxity
Accordingly, and in line with currently ongoing trials in HFpEF (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not
Losing around one to two pounds each week is ideal, but sometimes youll see more and sometimes, none at all
Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man
Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis combining 177 randomized controlled trials with a median follow-up of 26 weeks
For additional guidance, refer to the FY2026 ICD-10-CM Official Guidelines, the AHA Coding Clinic, and the Amputee Coalition Healthcare Professional Resources for clinical background on amputation rehabilitation
